Price & resources


Resources for help along the way.

You can download any of the resources on this page.

SUBLOCADE Education Brochure

Key things to know about SUBLOCADE.

Medication Guide

Summary of safety information about SUBLOCADE.

Spanish Patient Brochure

Key things to know about SUBLOCADE (Spanish).

Transition of Care for Patients

This brochure provides an overview of the information and processes associated with Transition of Care Support for enrolled patients.

Counseling Brochure

Learn about options and get prepared for a session.

INSUPPORT® Copay Assistance Program

Learn how the savings program for SUBLOCADE works.

Treatment Journey Brochure

Tips and questions to help you stay motivated and focused.

INSUPPORT® Copay Assistance Brochure for Patients

This brochure provides detailed information about the Copay Assistance Program for SUBLOCADE.

Patient Alert Card

This card can inform healthcare providers in emergencies.

Patient Alert Card

If you are receiving treatment with SUBLOCADE, download and print this Patient Alert Card and keep it with you at all times.

In case of a medical emergency, healthcare providers may ask for a person's medical history to help choose the appropriate medication. This Patient Alert Card will let healthcare providers know if someone is on buprenorphine extended-release. For a person on SUBLOCADE, it is important to instruct a family member or friend to, in the event of an emergency, inform the medical staff that the person is physically dependent on opioids and is being treated with SUBLOCADE.

Download Patient Alert Card

Find a SUBLOCADE treatment provider

For more information on how to find a facility, call INSUPPORT® at 1-844-467-7778.

Want information?

Find out more about opioid addiction and treating it.

Get Updates


What is the most important information I should know about SUBLOCADE?

Because of the serious risk of potential harm or death from self-injecting SUBLOCADE into a vein (intravenously), it is only available through a restricted program called the SUBLOCADE REMS Program.

SUBLOCADE contains an opioid medicine called buprenorphine that can cause serious and life-threatening breathing problems, especially if you take or use certain other medicines or drugs.

Talk to your healthcare provider about naloxone, a medicine available to patients for emergency treatment of an opioid overdose. If naloxone is given, you must call 911 or get emergency medical help right away to treat overdose or accidental use of an opioid.

SUBLOCADE may cause serious and life‐threatening breathing problems. Get emergency help right away if you:

Do not take certain medicines during treatment with SUBLOCADE. Taking other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) while on SUBLOCADE can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.

Death has been reported in those who are not opioid dependent who received buprenorphine sublingually.

Who should not take SUBLOCADE?

Do not use SUBLOCADE if you are allergic to buprenorphine or any ingredient in the prefilled syringe (ATRIGEL® Delivery System, a biodegradable 50:50 poly(DL-lactide-co-glycolide) polymer and a biocompatible solvent, N-methyl-2-pyrrolidone (NMP)).

Before starting SUBLOCADE, tell your healthcare provider about all of your medical conditions, including if you have:

Tell your healthcare provider if you are:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

What should I avoid while being treated with SUBLOCADE?

What are the possible side effects of SUBLOCADE?

SUBLOCADE can cause serious side effects, including:

These are not all the possible side effects. Call your healthcare provider for medical advice about side effects.

To report pregnancy or side effects associated with taking SUBLOCADE, please call 1-877-782-6966. You are encouraged to report negative side effects of drugs to the FDA. Visit or call 1-800-FDA-1088.


SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is a prescription medicine used to treat adults with moderate to severe addiction (dependence) to opioid drugs (prescription or illegal) who have received an oral transmucosal (used under the tongue or inside the cheek) buprenorphine-containing medicine at a dose that controls withdrawal symptoms for at least 7 days. SUBLOCADE is part of a complete treatment plan that should include counseling.

For more information about SUBLOCADE, see the full Prescribing Information including BOXED WARNING, and Medication Guide or talk to your healthcare provider. For REMS information visit